High-Frequency Spinal Cord Stimulation and Pregnancy: A Case Report

2015 ◽  
Vol 18 (8) ◽  
pp. 757-758 ◽  
Author(s):  
Caro Edelbroek ◽  
Michel Terheggen
2017 ◽  
Vol 1 (21;1) ◽  
pp. E177-E182
Author(s):  
Alan D. Kaye

Complex regional pain syndrome (CRPS) is a chronic, debilitating, neuropathic pain condition which is often misdiagnosed, difficult to manage, and lacks proven methods for remission. Most available methods provide some relief to a small percentage of patients. Recent FDA approval and superiority of the Nevro Senza 10-kHz high frequency (HF10) spinal cord stimulation (SCS) therapy over traditional low-frequency spinal cord stimulation for treatment of chronic back and leg pain may provide a new interventional therapeutic option for patients suffering from CRPS. We provide a case report of a 53-year-old Caucasian woman who suffered with CRPS in the right knee and thigh for over 7 years. Implantation of the HF10 device provided over 75% relief of pain, erythema, heat, swelling, and tissue necrosis to the entire region within 1 month of treatment. Because the HP10 therapy provides pain relief without paresthesia typical of traditional low-frequency, this system may provide relief for patients suffering from chronic pain. Key words: Complex regional pain syndrome, spinal cord stimulation, Nevro Senza HF10, erythema, knee, thigh


2018 ◽  
pp. 167-171
Author(s):  
Nick Vanquathem

Background: High frequency wireless Spinal Cord Stimulation (SCS) at the C1-C2 vertebral levels provides analgesia for the treatment of refractory ocular pain on the left side secondary to post-herpetic neuralgia. Objective: To assess analgesic effects of minimally invasive wireless neuromodulation in the treatment of chronic pain due to post-herpetic neuralgia. Study Design: This observational, prospective case report was designed to illustrate the effectiveness of relieving chronic, intractable pain utilizing wireless spinal cord stimulation at multiple frequencies for the treatment of post-herpetic neuralgia. Setting: Private Practice Interventional Pain Clinic. Methods: This is a single case study of a 62-yearold patient who experienced an episode of shingles with rash over the left frontal and lateral ocular margin. After the rash subsided, the patient began suffering from severe pain in the left eye. The patient was placed on a 10-day course of valacyclovir, gabapentin, which was discontinued secondary to sedation intolerance, pregabalin titrated to 300 mg/day and oxycodone, all of which were ineffective in relieving the pain. The patient received a stellate ganglion block injection on 6 occasions, experiencing pain relief of only up to one-day after each injection. Stellate ganglion radiofrequency ablation was also unsuccessful. With original Visual Analog Scale (VAS) score of 9/10, inability to sleep and incapacity to perform activities of daily living (ADLs), the patient had Stimwave Freedom wireless stimulators placed sequentially at the C1-C2 vertebral levels. Results: Programming at low frequencies from 40-120 Hz was unsuccessful in reducing left eye pain. Stimulation was increased to high frequency on the Stimwave SurgeTM adjustable waveform, and within 12 hours, the patient noted significant decrease in pain. At 3 days post-procedure, the patient’s VAS score was 1/10. The patient had permanent placement of the devices, and at 8-month follow-up, VAS scores were 0-2/10, and the patient’s mood, sleep and ability to perform ADLs all improved substantially. Limitations: The study was limited by the novelty of the device. Although the doctor who implanted the device is very experienced, more cases of the use of the wireless Stimwave Freedom apparatus are necessary to establish its long-term effectiveness and safety. More clinical trials investigating the utilization of multiple frequencies are also required. Conclusions: Epidural placement of 2, wireless sequentially placed octopolar stimulators with a minimally invasive technique at high frequency stimulation was safe and effective. Key words: post-herpetic neuralgia, ocular, spinal cord stimulation, wireless, shingles, trigeminal nerve, high frequency


2018 ◽  
Vol 12 (4) ◽  
pp. 217-219 ◽  
Author(s):  
Neil Majmundar ◽  
Eleonora Francesca Spinazzi ◽  
Joseph Doran ◽  
Antonios Mammis

Introduction: High-frequency (HF) spinal cord stimulation (SCS), a relatively new form of spinal cord stimulation, provides stimulation frequencies of up to 10 kHz and allows for paresthesia-free pain relief, an advantage that distinguishes it from traditional stimulation therapy. Without paresthesias, patients with HF SCS do not experience position-dependent painful stimulation and do not have to experience treatment interruption during sleep. Lead migration is a well-known complication of conventional spinal cord stimulation and usually results in a loss of efficacy along with other unpleasant sensory symptoms. In this case report, we present an incidence of lead migration in HF SCS that resulted in paresthesias, a symptom not expected to occur in this novel therapy. Case: The patient, a 60-year-old female with post-laminectomy syndrome, underwent a trial of HF SCS with standard lead placement at T8-T9. She initially had pain relief, but returned to the office on post-operative day 2 complaining of left chest wall and cardiac paresthesias, without frank pain or palpitations, in addition to loss of efficacy for her back and leg pain. Imaging showed that the leads had migrated, with one lead reaching the levels of T1-T3. Conclusion: While HF SCS has emerged as an effective paresthesia-free means of reducing back and leg pain, we provide the first report of paresthesias occurring with the HF SCS system as a result of cephalad lead migration. As HF SCS is only now being utilized as a treatment modality, we must remain cautious of potential adverse outcomes in patients, in particular above T8.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Chiaki Yamada ◽  
Aiko Maeda ◽  
Katsuyuki Matsushita ◽  
Shoko Nakayama ◽  
Kazuhiro Shirozu ◽  
...  

Abstract Background Patients with spinal cord injury (SCI) frequently complain of intractable pain that is resistant to conservative treatments. Here, we report the successful application of 1-kHz high-frequency spinal cord stimulation (SCS) in a patient with refractory neuropathic pain secondary to SCI. Case presentation A 69-year-old male diagnosed with SCI (C4 American Spinal Injury Association Impairment Scale A) presented with severe at-level bilateral upper extremity neuropathic pain. Temporary improvement in his symptoms with a nerve block implied peripheral component involvement. The patient received SCS, and though the tip of the leads could not reach the cervical vertebrae, a 1-kHz frequency stimulus relieved the intractable pain. Conclusions SCI-related symptoms may include peripheral components; SCS may have a considerable effect on intractable pain. Even when the SCS electrode lead cannot be positioned in the target area, 1-kHz high-frequency SCS may still produce positive effects.


Sign in / Sign up

Export Citation Format

Share Document